TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.72%)
As of: Sep 9, 2026 · 2:01 PM EDT

TAO Synergies (TAOX) Enterprise Value (2020 - 2026)

TAO Synergies' (TAOX) quarterly Enterprise Value came in at $25.5 million in Q2 2026, up 1305.52% on a YoY basis from $1.8 million in Q2 2025, and down 34.46% quarter-over-quarter from $38.9 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Enterprise Value (2020 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Enterprise Value for 7 consecutive years, with $25.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Enterprise Value rose 1305.52% year-over-year to $25.5 million; the trailing twelve-month figure through Jun 2026 stood at $25.5 million (up 1305.52% YoY), and the FY2025 full-year result was $6.6 million, up 151.17% from the prior year.
  • Enterprise Value slipped to $25.5 million in Q2 2026 per TAOX's latest filing, from $38.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $1.3 billion in Q1 2022 and bottomed at -$23.2 million in Q1 2024.
  • Historically, Enterprise Value has averaged $212.0 million across 5 years, with a median of $32.2 million in 2026.
  • The sharpest annual moves came in 2024 and 2026: Enterprise Value tumbled 126.46% in 2024, then jumped 1305.52% in 2026.
  • Over 5 years, Enterprise Value stood at $173.2 million in 2022, then plunged by 71.66% to $49.1 million in 2023, then sank by 126.46% to -$13.0 million in 2024, then jumped by 151.17% to $6.6 million in 2025, then surged by 283.25% to $25.5 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered $25.5 million, $38.9 million, and $6.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.98 Bn 196.99 Bn 7.24 Bn
2 Gilead Sciences 181.24 Bn 178.06 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.38 Bn 124.53 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.97 Bn 74.97 Bn 3.93 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn
6 Moderna 54.80 Bn 49.67 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.09 Bn 30.78 Bn 992.69 Mn
8 Biogen 31.34 Bn 30.05 Bn 1.96 Bn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.47 Mn
Mar 31, 2026 38.87 Mn
Dec 31, 2025 6.65 Mn
Sep 30, 2025 16.70 Mn
Jun 30, 2025 -2.11 Mn
Mar 31, 2025 -11.47 Mn
Dec 31, 2024 -12.99 Mn
Sep 30, 2024 -17.98 Mn
Jun 30, 2024 -22.30 Mn
Mar 31, 2024 -23.17 Mn
Dec 31, 2023 49.09 Mn
Sep 30, 2023 86.00 Mn
Jun 30, 2023 137.97 Mn
Mar 31, 2023 111.40 Mn
Dec 31, 2022 173.24 Mn
Sep 30, 2022 1.12 Bn
Jun 30, 2022 854.84 Mn
Mar 31, 2022 1.29 Bn
Dec 31, 2021 1.03 Bn
Sep 30, 2021 1.49 Bn